The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics and cancer spectrum among breast cancer patients with TP53 germline mutation from a single institution.
 
Ashley Woodson
Employment - Genome Medical
 
Aydah Al-Awadhi
Honoraria - AstraZeneca/Daiichi Sankyo; Lilly; Merck; Merck; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; MSD; Novartis/Pfizer; Roche
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Lilly; Merck; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer
 
Angelica Gutierrez
No Relationships to Disclose
 
Dawen Sui
No Relationships to Disclose
 
Roland Bassett
No Relationships to Disclose
 
Jessica Corredor
No Relationships to Disclose
 
Guillermina Lozano
Stock and Other Ownership Interests - PMV Pharma
Consulting or Advisory Role - PMV Pharma
 
Courtney Dinardo
Honoraria - Abbvie; Astellas Pharma; Bristol Myers Squibb Foundation; Daiichi Sankyo/Astra Zeneca; Ellipses Pharma; Genentech/Abbvie; GlaxoSmithKline; Schrodinger; SERVIER
Consulting or Advisory Role - Abbvie; AstraZeneca; Genmab; Molecular Partners; Rigel; Ryvu Therapeutics; Schrodinger; SERVIER
Research Funding - Abbvie; Astex Pharmaceuticals; BeiGene; Bristol-Myers Squibb/Celgene; Cleave Therapeutics; Foghorn Therapeutics; Immune-Onc Therapeutics; Jazz Pharmaceuticals; Loxo/Lilly; Remix Therapeutics; SERVIER
 
Banu Arun
Research Funding - AstraZeneca (Inst)